Next Generation News and Research

RSS

GORE Septal Occluder receives FDA approval for use in REDUCE clinical study

W. L. Gore & Associates today announced that the FDA has approved the use of the new GORE Septal Occluder for inclusion in the Gore REDUCE Clinical Study. Gore is introducing this latest technology in its Gore REDUCE Clinical Study for prevention of recurrent stroke in patent foramen ovale (PFO) patients.

22 Oct 2012

AMP report provides overview of next generation sequencing technology

The Association for Molecular Pathology published the report of the Whole Genome Analysis Working Group of the AMP Clinical Practice Committee in the November 2012 issue of The Journal of Molecular Diagnostics.

20 Oct 2012

New study decodes complete epigenome of chronic lymphocytic leukemia

Researchers of the University of Oviedo have contributed to decipher the first epigenomes of chronic lymphocytic leukemia.

20 Oct 2012

GENNET, BGI enter collaborative agreement for non-invasive fetal trisomy test

BGI, the world's largest genomics organization, and GENNET, a center for genetics, fetal medicine and assisted reproduction, jointly announced that they have entered a collaborative agreement on non-invasive fetal trisomy (NIFTY) test with the aim to significantly improve reproductive health in Czech and Slovak Republic. Th

17 Oct 2012

Females having multiple sexual partners may be more fertile

Researchers have discovered that females that have multiple sexual partners can be more fertile than those that are monogamous and, very surprisingly, that this is the result of an "overproduction" of sons. The study - still only published as a provisional article but already one of the most accessed in BCM Evolutionary Biology - helps to explain a puzzle that has been haunting evolutionary biologist for decades: why during a mating season so many females chase multiple sexual partners when one is enough to fertilize all her eggs and to do it is costly and dangerous.

15 Oct 2012

Cardioviva can help fill the gap between diet, exercise and drugs

Over half (52 percent) of supplement users are concerned about their heart health and 73 percent express an interest in natural, clinically proven solutions for cholesterol reduction, according to market research conducted by Micropharma Limited, a pioneer in the development of innovative and effective probiotics.

12 Oct 2012

Alverix receives FDA 510(k) clearance for new BD Veritor System kit

Alverix, Inc., a world leader in the design and manufacture of next-generation platforms for diagnostic Point-of-Care (POC) testing, today announced that BD Diagnostics, a segment of Becton Dickinson and Company, a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD VeritorTM System for Rapid Detection of respiratory syncytial virus (RSV).

12 Oct 2012

Viewpoints: Wis. Senate candidates Thompson, Baldwin offer competing views of health law; 'Disturbing lack' of oversight of compounding pharmacies

The meningitis outbreak that has sickened at least 119 people and killed 11 of them has laid bare a disturbing lack of regulatory oversight of pharmacies that mix drug compounds and ship them around the country. Unless Congress passes legislation to strengthen the hand of the Food and Drug Administration, the public will continue to be at risk from contaminated products.

11 Oct 2012

Genocea raises $30M in Series C financing round

Genocea Biosciences, Inc., a clinical-stage company advancing innovative T cell vaccines for infectious diseases, has raised $30 million in a Series C financing round.

10 Oct 2012

First Edition: October 10, 2012

Today's headlines include reports that GOP presidential candidate Mitt Romney has pledged that his presidential agenda does not include abortion legislation.

10 Oct 2012

Pieris achieves milestone in Anticalin discovery and development collaboration with Daiichi Sankyo

Pieris AG announced today the achievement of the first financial milestone in its discovery and development collaboration with Daiichi Sankyo Company Limited.

9 Oct 2012

Boston Scientific enters definitive agreement to acquire Rhythmia Medical

Boston Scientific Corporation has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.

9 Oct 2012

PENTAX Medical to release new EPK-i7000 video processor and i10 series endoscopes

PENTAX Medical, a healthcare industry leader in endoscopic imaging, will release the next generation High Definition (HD+) EPK-i7000 video processor and i10 series endoscopes during the United European Gastroenterology week from October 20-24, 2012 in Amsterdam, The Netherlands.

From PENTAX Medical Company 9 Oct 2012

Kaneka to launch new Protein A Chromatography Resin for purification of therapeutic antibodies

Kaneka Corporation on 19/09/2012, announces the launch of KANEKA KanCapA, a new Protein A Chromatography Resin for the purification of therapeutic antibodies.

8 Oct 2012

MannKind completes enrollment in AFREZZA Phase 3 clinical studies for type 1 and 2 diabetes

MannKind Corporation today announced that it has completed recruiting patients for two Phase 3 clinical studies of AFREZZA (insulin human [rDNA origin]), an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's to-be-marketed next-generation inhaler.

5 Oct 2012

Patients with eye diseases can benefit from ArtCornea

Blindness is often caused by corneal diseases. The established treatment is a corneal transplant, but in many cases this is not possible and donor corneas are often hard to come by. In the future, an artificial cornea could make up for this deficiency and save the vision of those affected.

5 Oct 2012

Next Generation News and Research

GORE Septal Occluder receives FDA approval for use in REDUCE clinical study

AMP report provides overview of next generation sequencing technology

New study decodes complete epigenome of chronic lymphocytic leukemia

GENNET, BGI enter collaborative agreement for non-invasive fetal trisomy test

Females having multiple sexual partners may be more fertile

Cardioviva can help fill the gap between diet, exercise and drugs

Alverix receives FDA 510(k) clearance for new BD Veritor System kit

Viewpoints: Wis. Senate candidates Thompson, Baldwin offer competing views of health law; 'Disturbing lack' of oversight of compounding pharmacies

Genocea raises $30M in Series C financing round

First Edition: October 10, 2012

Pieris achieves milestone in Anticalin discovery and development collaboration with Daiichi Sankyo

Boston Scientific enters definitive agreement to acquire Rhythmia Medical

PENTAX Medical to release new EPK-i7000 video processor and i10 series endoscopes

Kaneka to launch new Protein A Chromatography Resin for purification of therapeutic antibodies

MannKind completes enrollment in AFREZZA Phase 3 clinical studies for type 1 and 2 diabetes

Patients with eye diseases can benefit from ArtCornea

Lecture to discuss insights into genes and neurodegenerative diseases gleaned from baker's yeast

Biologists combine laser cutting technology with modern sequencing to analyze gene activity in fungi

Humble Surgical Hospital acquires Mazor Robotics’ Renaissance system

Rotator cuff anchor launched by DePuy Mitek

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News